Antidepressant Prescribing in England: Patterns and Costs.


Journal

The primary care companion for CNS disorders
ISSN: 2155-7780
Titre abrégé: Prim Care Companion CNS Disord
Pays: United States
ID NLM: 101547532

Informations de publication

Date de publication:
16 Apr 2020
Historique:
received: 29 09 2019
accepted: 30 12 2019
entrez: 18 4 2020
pubmed: 18 4 2020
medline: 16 1 2021
Statut: epublish

Résumé

The number of prescriptions for antidepressants (ADs) in England and Wales has almost doubled in the past decade. The objective of this article is to describe the current prescribing rates of different antidepressants by general practice (GP) practice. We collated the prescribing behavior in each GP practice in the year April 1, 2017, to March 31, 2018. The monthly GP practice prescribing data reports for medication prescribing for each British National Formulary code and practice, as well as the prescriptions, quantity, and costs were examined in relation to prescribing practice. The data showed that 2.1 billion doses of antidepressant were prescribed to a total population of 52 million people. That equates to 11% of individuals taking ≥ 1 antidepressants on any day. Selective serotonin reuptake inhibitors (SSRIs) were the most prescribed class of ADs, with sertraline the most prescribed SSRI. The other most prescribed ADs were citalopram, fluoxetine, and mirtazapine. Some older agents, such as trimipramine and doxepin, are prescribed at a very high tariff. Broadly, the findings are in keeping with National Institute for Health and Care Excellence guidance in that the bulk of prescriptions were for SSRIs. Regular audit of patient treatment at a general practice level will ensure appropriate targeted use of licensed medications as supported by the evidence base.

Identifiants

pubmed: 32302071
doi: 10.4088/PCC.19m02552
doi:
pii:

Substances chimiques

Antidepressive Agents 0
Serotonin Uptake Inhibitors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Copyright 2020 Physicians Postgraduate Press, Inc.

Auteurs

Adrian H Heald (AH)

Department of Diabetes and Endocrinology, Salford Royal Hospital, Stott Lane, Salford, Greater Manchester M6 8HD, UK. adrian.heald@manchester.ac.uk.
The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, United Kingdom.
Department of Diabetes and Endocrinology, Salford Royal Hospital, Salford, United Kingdom.

Mike Stedman (M)

Res Consortium, Healthcare Improvement, Andover, United Kingdom.

Mark Davies (M)

Res Consortium, Healthcare Improvement, Andover, United Kingdom.

Mark Livingston (M)

Black Country Pathology Services, Walsall Manor Hospital, Walsall, United Kingdom.

David Taylor (D)

South London and the Maudsley NHS Foundation Trust, Beckenham, United Kingdom.

Roger Gadsby (R)

Warwick University Medical School, University of Warwick, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH